Literature DB >> 7810613

Subcellular distribution of dystrophin in isolated adult and neonatal cardiac myocytes.

J S Frank1, G Mottino, F Chen, V Peri, P Holland, B S Tuana.   

Abstract

The subcellular localization of dystrophin was examined in adult rabbit and rat cardiac myocytes with immunofluorescence and at higher resolution with immunogold. The aim was to resolve the conflicting reports on the presence of dystrophin in the transverse tubules (T tubules) of cardiac muscle and to determine its distribution in neonatal myocytes before and during the development of the T tubules. Dystrophin was localized to the peripheral sarcolemma and the T-tubular membrane and was absent from the intercalated disk membranes. In addition, dystrophin localization was followed with immunofluorescence in developing rabbit myocytes at 4 days, 1 wk, and 1 mo after birth. At 4 days of age, T tubules are absent and dystrophin was localized only in the peripheral sarcolemma. Dystrophin was present in the developing T tubules at 1 wk and 1 mo. These results imply that dystrophin is expressed in the T tubules as soon as they develop and confirm the different distribution of dystrophin in the T tubules of cardiac and skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7810613     DOI: 10.1152/ajpcell.1994.267.6.C1707

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Cardiac syntrophin isoforms: species-dependent expression, association with dystrophin complex and subcellular localization.

Authors:  Yuko Iwata; Munekazu Shigekawa; Shigeo Wakabayashi
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

2.  Is TGF-β1 (Transforming Growth Factor-β1) an Enabler of Myofibroblast-Cardiomyocyte Cross Talk?

Authors:  Kuljeet Kaur; José Jalife
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-05

3.  Simultaneous dystrophin and dysferlin deficiencies associated with high-level expression of the coxsackie and adenovirus receptor in transgenic mice.

Authors:  Christian A Shaw; Nancy Larochelle; Roy W R Dudley; Hanns Lochmuller; Gawiyou Danialou; Basil J Petrof; George Karpati; Paul C Holland; Josephine Nalbantoglu
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

4.  Surface:volume relationship in cardiac myocytes studied with confocal microscopy and membrane capacitance measurements: species-dependence and developmental effects.

Authors:  H Satoh; L M Delbridge; L A Blatter; D M Bers
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

Review 5.  Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy.

Authors:  Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

6.  Dystrophin and the cardiomyocyte membrane cytoskeleton in the healthy and failing heart.

Authors:  R R Kaprielian; N J Severs
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

7.  Possible molecular mechanisms underlying age-related cardiomyocyte apoptosis in the F344XBN rat heart.

Authors:  Sunil K Kakarla; Kevin M Rice; Anjaiah Katta; Satyanarayana Paturi; Miaozong Wu; Madhukar Kolli; Saba Keshavarzian; Kamran Manzoor; Paulette S Wehner; Eric R Blough
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-01-07       Impact factor: 6.053

8.  Sarcolemmal fragility secondary to the degradation of dystrophin in dilated cardiomyopathy, as estimated by electron microscopy.

Authors:  Tomie Kawada; Chieko Hemmi; Satoru Fukuda; Asaki Tezuka; Kuniaki Iwasawa; Mikio Nakazawa; Hiroshi Sato; Teruhiko Toyo-Oka
Journal:  Exp Clin Cardiol       Date:  2003

9.  Postnatal changes in caldesmon expression and localization in cardiac myocytes.

Authors:  Gail A McMartin; Erwin Wirch; Natalia Abraham; Gary J Kargacin
Journal:  J Anat       Date:  2003-10       Impact factor: 2.610

10.  Dystrophin is required for the normal function of the cardio-protective K(ATP) channel in cardiomyocytes.

Authors:  Laura Graciotti; Jodi Becker; Anna Luisa Granata; Antonio Domenico Procopio; Lino Tessarollo; Gianluca Fulgenzi
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.